Skip to search formSkip to main contentSkip to account menu

peramivir

Known as: (1S,2S,3R,4R)-3-((1S)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino-2-hydroxycyclopentanecarboxylic acid, trihydrate, 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid, 3-(1-acetamido-2-ethyl-butyl)-4-guanidino-2-hydroxy-cyclopentane-1-carboxylic acid 
A cyclopentane derivative with activity against influenza A and B viruses. Peramivir is a neuraminidase inhibitor which prevents normal processing of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
OBJECTIVE Neuraminidase (sialidase) inhibitors are considered to delay platelet clearance through the inhibition of platelet… 
2018
2018
To determine the differences in the clinical features of hospitalized elderly patients with influenza between the A (H1N1) pdm09… 
2018
2018
Preliminary results of construction of overall model for prediction of IC50 value of ligands of influenza virus neuraminidase of… 
2013
2013
Objective To study the pharmacokinetics of peramivir trihydrate and sodium chloride injection in Chinese healthy volunteers… 
Review
2011
Review
2011
Recent data suggest that organ transplant recipients are at high risk of complications of H1N1 influenza infection (1, 2). In… 
2009
2009
Objective:To detect side reaction products formed in peramivir synthesis with electrospray ionization-tandem mass spectrometry… 
2009
2009
Objective:To develop a liquid chromatography/tandem mass spectrometry employing precolumn derivatization method for determination… 
2006
2006
La presente invention concerne une composition de peramivir a activite orale amelioree. Cette composition comprend un adduct…